Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Jeremy Penner

6PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsRespiratory diseasesBehavioural epidemiologyMajor global burdens of diseaseFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Mar 13, 2026
The dolutegravir failure cohort: A multi-country longitudinal cohort with a randomised clinical trial of continued dolutegravir versus switch to darunavir in people with viraemia while on dolutegravir in Sub-Saharan Africa (The Ndovu Study) protocol.

Loice Achieng Ombajo, Joseph Nkuranga, Jeremy Penner

|Nov 24, 2025
First-Line Switch to B/F/TAF for Treatment of HIV in Older Adults ≥60 Years in Kenya (the B/F/TAF-Elderly Study).

Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga

|Nov 26, 2024
Change in Blood Pressure, Weight, and Other Cardiovascular Disease Risk Factors After Switch From Protease Inhibitors to Dolutegravir: Post hoc Analysis of the 48-week Randomised Second-line Switch to Dolutegravir Trial.

Loice Achieng Ombajo, Jeremy Penner, Joseph Nkuranga

|Nov 21, 2024
High prevalence of osteoporosis among virally suppressed older people (≥60 years) living with HIV.

Jeremy Penner, Loice A Ombajo, Joseph Nkuranga

|Jun 23, 2023
High rates of kidney impairment among older people (≥ 60 years) living with HIV on first-line antiretroviral therapy at screening for a clinical trial in Kenya.

Jeremy Penner, Loice Achieng Ombajo, Davies Otieno

|Nov 29, 2021
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study.

Matthew L Romo, Rena C Patel, Jessie K Edwards

Pageof 1

Frequent Collaborators

4 joint publications

Loice Achieng Ombajo

2 joint publications

Rena Patel

2 joint publications

Anton Pozniak

2 joint publications

Joseph Nkuranga

1 joint publications

Matthew L Romo

1 joint publications

Jessie K Edwards

1 joint publications

Leonard King'wara

1 joint publications

Caitlin Bernard

1 joint publications

Ellen Brazier

1 joint publications

Sandra Wagner Cardoso

Frequent Collaborators

4 joint publications

Loice Achieng Ombajo

2 joint publications

Rena Patel

2 joint publications

Anton Pozniak

2 joint publications

Joseph Nkuranga

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

18.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on : Mar 30, 2014

19.0K
See more related videos

Top Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on : Apr 09, 2014

18.5K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on : Mar 30, 2014

19.0K
See more related videos